ertapenem has been researched along with cefotetan in 11 studies
| Studies (ertapenem) | Trials (ertapenem) | Recent Studies (post-2010) (ertapenem) | Studies (cefotetan) | Trials (cefotetan) | Recent Studies (post-2010) (cefotetan) |
|---|---|---|---|---|---|
| 850 | 89 | 485 | 522 | 137 | 24 |
| Protein | Taxonomy | ertapenem (IC50) | cefotetan (IC50) |
|---|---|---|---|
| DNA dC->dU-editing enzyme APOBEC-3G isoform 1 | Homo sapiens (human) | 69.3 | |
| DNA dC->dU-editing enzyme APOBEC-3A isoform a | Homo sapiens (human) | 29.6 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 9 (81.82) | 29.6817 |
| 2010's | 2 (18.18) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Baptista, BC; Correia, JD; da Fonseca, JD; MartÃnez-MartÃnez, L; Pomba, C | 1 |
| Borgianni, L; Docquier, JD; Hanson, ND; Prandi, S; Rossolini, GM; Salden, L; Santella, G | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Abramson, MA; Awad, SS; Finn, TS; Itani, KM; Jensen, EH; Wilson, SE | 2 |
| Sexton, DJ | 1 |
| Abramson, MA; Finn, TS; Itani, KM; Jensen, EH; Tomassini, JE | 1 |
| Abramson, MA; Itani, KM; Jensen, EH; Kumar, RN; Pellissier, JM; Turpin, RS; Wilson, SE | 1 |
| Abramson, MA; Itani, K; Jensen, E; Suding, P; Wilson, SE | 1 |
| Abramson, MA; Citron, DM; Goldstein, EJ; Merriam, CV | 1 |
1 review(s) available for ertapenem and cefotetan
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
6 trial(s) available for ertapenem and cefotetan
| Article | Year |
|---|---|
Ertapenem versus cefotetan prophylaxis in elective colorectal surgery.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Anti-Bacterial Agents; Antibiotic Prophylaxis; beta-Lactams; Cefotetan; Clostridioides difficile; Clostridium Infections; Colorectal Surgery; Double-Blind Method; Elective Surgical Procedures; Ertapenem; Female; Humans; Infusions, Intravenous; Logistic Models; Male; Middle Aged; Prospective Studies; Risk Factors; Surgical Wound Infection; Treatment Failure | 2006 |
Polyethylene glycol versus sodium phosphate mechanical bowel preparation in elective colorectal surgery.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Cathartics; Cefotetan; Colectomy; Colon; Ertapenem; Female; Humans; Male; Middle Aged; Phosphates; Polyethylene Glycols; Preoperative Care; Randomized Controlled Trials as Topic; Rectum; Surgical Wound Infection | 2007 |
Effect of body mass index and ertapenem versus cefotetan prophylaxis on surgical site infection in elective colorectal surgery.
Topics: Adult; Aged; Aged, 80 and over; Antibiotic Prophylaxis; beta-Lactams; Body Mass Index; Cefotetan; Colon; Digestive System Surgical Procedures; Ertapenem; Female; Humans; Male; Middle Aged; Obesity; Rectum; Retrospective Studies; Surgical Wound Infection | 2008 |
Comparative costs of ertapenem and cefotetan as prophylaxis for elective colorectal surgery.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; beta-Lactams; Cefotetan; Colorectal Surgery; Cost-Benefit Analysis; Elective Surgical Procedures; Ertapenem; Female; Hospital Costs; Humans; Length of Stay; Male; Middle Aged; Surgical Wound Infection; Treatment Failure; Treatment Outcome | 2008 |
Definitive risk factors for anastomotic leaks in elective open colorectal resection.
Topics: Aged; Anastomosis, Surgical; Anti-Bacterial Agents; Antibiotic Prophylaxis; beta-Lactams; Cefotetan; Colectomy; Elective Surgical Procedures; Ertapenem; Female; Humans; Male; Middle Aged; Multivariate Analysis; Prospective Studies; Risk Factors; Serum Albumin | 2008 |
Infection after elective colorectal surgery: bacteriological analysis of failures in a randomized trial of cefotetan vs. ertapenem prophylaxis.
Topics: Antibiotic Prophylaxis; Bacteria; Bacteria, Aerobic; Bacteria, Anaerobic; Bacterial Infections; beta-Lactams; Cefotetan; Colon; Elective Surgical Procedures; Ertapenem; Humans; Microbial Sensitivity Tests; Rectum; Surgical Wound Infection; Treatment Failure | 2009 |
4 other study(ies) available for ertapenem and cefotetan
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Detection of the pandemic O25-ST131 human virulent Escherichia coli CTX-M-15-producing clone harboring the qnrB2 and aac(6')-Ib-cr genes in a dog.
Topics: Animals; Anti-Bacterial Agents; Dogs; Drug Resistance, Bacterial; Escherichia coli; Genes, Bacterial; Humans; Plasmids; Virulence | 2009 |
Genetic context and biochemical characterization of the IMP-18 metallo-beta-lactamase identified in a Pseudomonas aeruginosa isolate from the United States.
Topics: Amino Acid Sequence; Bacterial Proteins; beta-Lactamases; beta-Lactams; Ertapenem; Meropenem; Microbial Sensitivity Tests; Models, Genetic; Molecular Sequence Data; Open Reading Frames; Pseudomonas aeruginosa; Sequence Homology, Amino Acid; Thienamycins; United States | 2011 |
Carbapenems for surgical prophylaxis?
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; beta-Lactams; Cefotetan; Colorectal Surgery; Drug Resistance, Bacterial; Elective Surgical Procedures; Ertapenem; Humans; Surgical Wound Infection; Treatment Failure | 2006 |